Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 9/20 | 0.47 |
| ▸ | FNTB | P49356 | 7/20 | 0.47 |
| ▸ | BTN3A1 | O00481 | 4/20 | 0.44 |
| ▸ | LPAR3 | Q9UBY5 | 7/20 | 0.39 |
| ▸ | LPAR2 | Q9HBW0 | 5/20 | 0.39 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.39 |
| ▸ | PGGT1B | P53609 | 3/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30974602 | 0.82 | FNTA (0.39) | FNTAFNTBBTN3A1LPAR3LPAR2 | |
| SCHEMBL20506749 | 0.80 | FNTA (0.68) | FNTAFNTBBTN3A1PGGT1B | |
| SCHEMBL8439565 | 0.80 | BTN3A1 (0.52) | FNTAFNTBBTN3A1LPAR3LPAR2 | |
| SCHEMBL20530992 | 0.78 | LPAR3 (0.47) | FNTAFNTBBTN3A1LPAR3LPAR2 | |
| SCHEMBL17140229 | 0.76 | BTN3A1 (0.69) | FNTAFNTBBTN3A1PGGT1B | |
| SCHEMBL1004250 | 0.76 | BTN3A1 (0.69) | FNTAFNTBBTN3A1PGGT1B | |
| Phosphoric Acid SCHEMBL27617050 | 0.74 | BTN3A1 (0.67) | FNTAFNTBBTN3A1PGGT1B | |
| Ammonia Solution, Strong SCHEMBL29405488 | 0.74 | BTN3A1 (0.67) | FNTAFNTBBTN3A1PGGT1B | |
| Phosphoric Acid SCHEMBL27448378 | 0.74 | BTN3A1 (0.67) | FNTAFNTBBTN3A1PGGT1B | |
| Ammonia Solution, Strong SCHEMBL27094918 | 0.74 | BTN3A1 (0.67) | FNTAFNTBBTN3A1PGGT1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0528113-B1 | Method of preparing flame-retarding expandable poly-phenylene ether/polystyrene graft copolymers | GEN ELECTRIC (US) | 1996-10-23 | — | — | EP | claimed |
| CN-118574673-A | Supported hydrotreating catalyst with enhanced activity | 科琴荷兰私人有限公司 | 2024-08-30 | — | — | CN | disclosed |
| US-20240269337-A1 | METHOD AND SYSTEM FOR COATING FILTER MEDIA | MOLECULAR PLASMA GROUP SA (LU) | 2024-08-15 | — | — | US | disclosed |
| EP-4121220-B1 | PLASMA COATING TREATMENT METHOD FOR INHIBITING BIOLOGICAL PATHOGEN TRANSFER | MOLECULAR PLASMA GROUP SA (LU) | 2024-04-24 | — | — | EP | disclosed |
| EP-4347914-A1 | METHOD AND SYSTEM FOR COATING FILTER MEDIA | Molecular Plasma Group SA (LU) | 2024-04-10 | — | — | EP | disclosed |
| EP-4347087-A1 | METHOD FOR COATING FILTER MEDIA AND FILTER MEDIA OBTAINED THEREFROM | Deltrian International SA (BE) | 2024-04-10 | — | — | EP | disclosed |
| EP-4294772-A1 | FIRE-RESISTANT GLAZING | Saint-Gobain Glass France (FR) | 2023-12-27 | — | — | EP | disclosed |
| US-20230175195-A1 | PLASMA COATING TREATMENT METHOD FOR INHIBITING BIOLOGICAL PATHOGEN TRANSFER | MOLECULAR PLASMA GROUP S.A. (LU) | 2023-06-08 | — | — | US | disclosed |
| EP-4121220-A1 | PLASMA COATING TREATMENT METHOD FOR INHIBITING BIOLOGICAL PATHOGEN TRANSFER | Molecular Plasma Group SA (LU) | 2023-01-25 | — | — | EP | disclosed |
| WO-2022248610-A1 | METHOD AND SYSTEM FOR COATING FILTER MEDIA | MOLECULAR PLASMA GROUP SA (LU) | 2022-12-01 | — | — | WO | disclosed |
| WO-2022248604-A1 | METHOD FOR COATING FILTER MEDIA AND FILTER MEDIA OBTAINED THEREFROM | DELTRIAN INTERNATIONAL SA (BE) | 2022-12-01 | — | — | WO | disclosed |
| EP-4095283-A1 | METHOD AND SYSTEM FOR COATING FILTER MEDIA | Molecular Plasma Group SA (LU) | 2022-11-30 | — | — | EP | disclosed |
| CN-115175957-A | Chemical modification process for polymer components | 原子能和替代能源委员会 | 2022-10-11 | — | — | CN | disclosed |
| WO-2022175623-A1 | FIRE‑RESISTANT GLAZING | SAINT-GOBAIN GLASS FRANCE (FR) | 2022-08-25 | — | — | WO | disclosed |
| WO-2021185933-A1 | PLASMA COATING TREATMENT METHOD FOR INHIBITING BIOLOGICAL PATHOGEN TRANSFER | MOLECULAR PLASMA GROUP S.A. (LU) | 2021-09-23 | — | — | WO | disclosed |
| EP-3881942-A1 | PLASMA COATING TREATMENT METHOD FOR INHIBITING BIOLOGICAL PATHOGEN TRANSFER | Molecular Plasma Group SA (LU) | 2021-09-22 | — | — | EP | disclosed |
| US-10471465-B2 | Method for forming regular polymer thin films using atmospheric plasma deposition | LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY (LIST) (LU) | 2019-11-12 | — | — | US | disclosed |
| EP-3140047-B1 | METHOD FOR FORMING REGULAR POLYMER THIN FILMS USING ATMOSPHERIC PLASMA DEPOSITION | LUXEMBOURG INST SCIENCE & TECH LIST (LU) | 2019-04-24 | — | — | EP | disclosed |
| EP-3140047-A1 | METHOD FOR FORMING REGUAL POLYMER THIN FILMS USING ATMOSPHERIC PLASMA DEPOSITION | Luxembourg Institute of Science and Technology (LIST) (LU) | 2017-03-15 | — | — | EP | disclosed |
| US-20170050214-A1 | Method for Forming Regular Polymer Thin Films Using Atmospheric Plasma Deposition | LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY (LIST) (LU) | 2017-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230175195-A1 | PLASMA COATING TREATMENT METHOD FOR INHIBITING BIOLOGICAL PATHOGEN TRANSFER | TFPI, TTPA, CD4 | FNTA 148/4885FNTB 330/4885BTN3A1 389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.